• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清核糖核酸酶升高作为胰腺肿瘤标志物的非特异性

Non-specificity of elevated serum ribonuclease as a pancreatic tumour marker.

作者信息

Isaacs P

出版信息

Digestion. 1981;22(2):101-7. doi: 10.1159/000198603.

DOI:10.1159/000198603
PMID:7274605
Abstract

Differences in heart stability of human pancreatic ribonuclease (cRNase) and serum ribonuclease were abolished by aprotinin, suggesting that the pancreatic enzyme was similar to the serum enzyme, but was being destroyed by proteases. Serum ribonuclease levels in normal subjects correlated with age but were unaffected by meal ingestion. Serum ribonuclease was not found to be useful in the detection of pancreatic cancer and was more frequently abnormal in patients with other solid tumours or renal failure.

摘要

抑肽酶消除了人胰腺核糖核酸酶(cRNase)和血清核糖核酸酶在心脏稳定性上的差异,这表明胰腺酶与血清酶相似,但正被蛋白酶破坏。正常受试者的血清核糖核酸酶水平与年龄相关,但不受进食影响。血清核糖核酸酶在胰腺癌检测中并无用处,在其他实体瘤或肾衰竭患者中更常出现异常。

相似文献

1
Non-specificity of elevated serum ribonuclease as a pancreatic tumour marker.血清核糖核酸酶升高作为胰腺肿瘤标志物的非特异性
Digestion. 1981;22(2):101-7. doi: 10.1159/000198603.
2
Immunological assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer.血清中胰腺核糖核酸酶的免疫测定作为胰腺癌的一个指标
Cancer Res. 1984 Apr;44(4):1682-7.
3
Ribonuclease as a tumour marker for pancreatic carcinoma.核糖核酸酶作为胰腺癌的肿瘤标志物
J Clin Pathol. 1980 Dec;33(12):1212-3. doi: 10.1136/jcp.33.12.1212.
4
Combined evaluation of serum ribonuclease and ferritin: any advantages in pancreatic cancer diagnosis?血清核糖核酸酶与铁蛋白联合评估:在胰腺癌诊断中有何优势?
Oncology. 1984;41(6):393-5. doi: 10.1159/000225861.
5
[The activity of serum ribonuclease in pancreatic cancer].[胰腺癌患者血清核糖核酸酶的活性]
Nihon Shokakibyo Gakkai Zasshi. 1982 Nov;79(11):2132-6.
6
[Diagnostic values of serum ribonuclease activities in pancreatic carcinoma (author's transl)].血清核糖核酸酶活性在胰腺癌中的诊断价值(作者译)
Rinsho Byori. 1980 Nov;28(11):1141-4.
7
"Plasma"-type ribonuclease in pancreatic cancer diagnosis: a critical appraisal.胰腺癌诊断中的“血浆”型核糖核酸酶:批判性评估
Hepatogastroenterology. 1981 Dec;28(6):316-8.
8
Assessment of the clinical usefulness of serum ribonuclease assays: an indicator for the detection of pancreatic cancer.血清核糖核酸酶检测临床实用性评估:一种检测胰腺癌的指标
Gastroenterol Jpn. 1979;14(1):55-62. doi: 10.1007/BF02774605.
9
Determination of ribonuclease activity in serum of patients with pancreatic necrosis. An attempt of extending the enzyme diagnosis of acute pancreatitis.
Z Med Lab Diagn. 1989;30(8):425-30.
10
Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer.血清核糖核酸酶在胰腺癌诊断中的敏感性和特异性。
Am J Surg. 1980 Jan;139(1):27-32. doi: 10.1016/0002-9610(80)90225-1.

引用本文的文献

1
Emerging biological functions of ribonuclease 1 and angiogenin.核糖核酸酶 1 和血管生成素的新兴生物学功能。
Crit Rev Biochem Mol Biol. 2022 Jun;57(3):244-260. doi: 10.1080/10409238.2021.2004577. Epub 2021 Dec 9.
2
The RNase a superfamily: generation of diversity and innate host defense.核糖核酸酶a超家族:多样性的产生与宿主天然防御
Mol Divers. 2006 Nov;10(4):585-97. doi: 10.1007/s11030-006-9028-2.
3
Ribonuclease and ribonuclease inhibitor in the human pancreas.人胰腺中的核糖核酸酶和核糖核酸酶抑制剂
Gastroenterol Jpn. 1983 Oct;18(5):468-73. doi: 10.1007/BF02776587.
4
Ribonuclease and ribonuclease inhibitor in the human pancreas.人胰腺中的核糖核酸酶和核糖核酸酶抑制剂。
Gastroenterol Jpn. 1983 Jun;18(3):252-4. doi: 10.1007/BF02774968.
5
Relationship between pancreatic enzymes and pathological changes in the pancreas in acute pancreatitis. The significance of determination of serum deoxyribonuclease.急性胰腺炎时胰腺酶与胰腺病理变化的关系。血清脱氧核糖核酸酶测定的意义。
Int J Pancreatol. 1989 May;4(4):371-81. doi: 10.1007/BF02938473.
6
Serum ribonuclease activity in the diagnosis of pancreatic disease.血清核糖核酸酶活性在胰腺疾病诊断中的应用
Int J Pancreatol. 1991 Jan;8(1):23-33. doi: 10.1007/BF02930220.